PFIZER LIMITED header image

PFIZER LIMITED

500680

Equity

ISIN INE182A01018 / Valor 912046

Bombay Stock Exchange Ltd. (Mumbai) (2026-07-03)
INR 4,565.20+2.87%

PFIZER LIMITED
UMushroom community rating:

star star star star star
0.00 0 votes No rating yet
NegativeNeutralPositive

About company

Pfizer Limited is the local operating arm of Pfizer Inc., functioning as a manufacturer, marketer and distributor of prescription medicines and vaccines while supporting clinical research and regulatory activities in its market. The company commercializes treatments across a range of therapeutic areas — notably oncology, vaccines (including its COVID‑19 mRNA vaccine developed with BioNTech), internal medicine, inflammation and immunology, and rare diseases — and works with hospitals, clinics, pharmacies and government programs to supply products and run clinical trials. Its business model combines in‑house and partnered R&D, manufacturing and licensing arrangements to bring patented branded therapies to market, generate revenue through product sales and secured procurement contracts, and manage the regulatory and reimbursement processes that determine market access.

Summarized from source with an LLMView SourceSector: Healthcare

Latest Results ():

Summarized from source with an LLMView Source

Key figures

-21.1%1Y
20.5%3Y
-20.2%5Y

Performance

24.3%1Y
25.2%3Y
23.3%5Y

Volatility

Market cap

2189 M

Market cap (USD)

Daily traded volume (Shares)

1,485

Daily traded volume (Shares)

1 day high/low

/

1 day high/low (USD)

52 weeks high/low

0.00 / 0.00

52 weeks high/low (USD)

Dividend ex-date

01 January, 2022

Dividend ex-date

Dividend

0.00

Dividend (USD)

Dividend yield (p.a.)

0.00%

Dividend yield (p.a.)

0.002022
0.002023
0.002024

Est dividend (USD)

0.00%2022
0.00%2023
0.00%2024

Est dividend yield

P/E ratio

10.00

P/E ratio

00.002022
00.002023
00.002024

Est P/E ratio

EPS

0.00

EPS (USD)

0.002022
0.002023
0.002024

Est EPS (USD)

Ratings & reviews

star star star star star

0.00

0 votes
Performance:
starstarstarstarstar
0.00
Innovation:
starstarstarstarstar
0.00
Society:
starstarstarstarstar
0.00
Nature:
starstarstarstarstar
0.00

EQUITIES OF THE SAME SECTOR

Ultragenyx Pharmaceutical Inc
Ultragenyx Pharmaceutical Inc Ultragenyx Pharmaceutical Inc Valor: 22860122
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
3.37%USD 33.47
Pacira BioSciences Inc
Pacira BioSciences Inc Pacira BioSciences Inc Valor: 12338490
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
1.44%USD 25.39
Alembic Pharmaceuticals Limited
Alembic Pharmaceuticals Limited Alembic Pharmaceuticals Limited Valor: 11500585
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.91%INR 822.60
Boston Scientific Corp
Boston Scientific Corp Boston Scientific Corp Valor: 913577
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
4.83%USD 45.14
Cohance Lifesciences Ltd
Cohance Lifesciences Ltd Cohance Lifesciences Ltd Valor: 46346459
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.62%INR 454.85
Teladoc Health Inc
Teladoc Health Inc Teladoc Health Inc Valor: 28438140
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
1.10%USD 9.20
Rhythm Pharmaceuticals Inc
Rhythm Pharmaceuticals Inc Rhythm Pharmaceuticals Inc Valor: 25337263
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
3.41%USD 114.17
Amphastar Pharmaceuticals Inc
Amphastar Pharmaceuticals Inc Amphastar Pharmaceuticals Inc Valor: 24511852
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-2.29%USD 19.64
The Platform Group AG
The Platform Group AG The Platform Group AG Valor: 57796644
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
1.69%EUR 0.96
Unitedhealth Group Inc
Unitedhealth Group Inc Unitedhealth Group Inc Valor: 1078451
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-0.28%USD 425.36